Atlas Trials

Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients

Clinical trial NCT01416402 · COMPLETED

Trial details

NCT number
NCT01416402
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HyperuricemiaGout
Start date
2011-08-01
Primary completion
2011-10-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.